Literature DB >> 10822136

Differential inhibition of renal cancer cell invasion mediated by fibronectin, collagen IV and laminin.

W Brenner1, S Gross, F Steinbach, S Horn, R Hohenfellner, J W Thüroff.   

Abstract

Invasion of tumor cells into the extracellular matrix is an essential step in the formation of metastases in renal cancer. Cell adhesion molecules such as beta(1)-integrins, which bind to the RGD sequence (arginine-glycine-asparagine) and CD44 are involved in this process. We examined the invasion of a renal carcinoma cell line (CCF-RC1) into the extracellular matrix compounds fibronectin, collagen IV and laminin and the effect of TGFbeta and IFNgamma on this process. The inhibitory effect of an antibody against the beta(1)-subunit of integrins (CD29), as well as a pentapeptide including the RGD sequence, was also evaluated. A micro-chemotaxis chamber, including a polycarbonate membrane with a pore diameter of 8 microm, was used for quantification of cell migration. The addition of the extracellular matrix compounds fibronectin, laminin and collagen IV resulted in a 5-10-fold increase in invasion. This increased invasion depends strongly on the presence of beta(1)-integrins, shown by the use of an antibody against CD29 or a RGD including peptide which inhibit the cell migration by approximately 88%. CD44 is less involved in collagen IV dependent migration and almost no influence of CD44 was observed on a fibronectin and laminin dependent migration. TNFalpha and IFNgamma did not significantly influence the expression of CD29 or CD44, and no alteration in tumor cell migration was observed. These results show that the invasion of renal cancer cells is differentially regulated by compounds of the extracellular matrix, whereby fibronectin seems to be the most critical factor. The molecular interactions in this process are strongly dependent on beta(1)-integrins and the corresponding amino acid sequence RGD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822136     DOI: 10.1016/s0304-3835(00)00429-8

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.

Authors:  Kavitha Sivasubramaniyan; Abhishek Harichandan; Karin Schilbach; Andreas F Mack; Jens Bedke; Arnulf Stenzl; Lothar Kanz; Gerhard Niederfellner; Hans-Jörg Bühring
Journal:  Glycobiology       Date:  2015-05-15       Impact factor: 4.313

2.  Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Authors:  Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

3.  Evaluation of cellular fibronectin plasma levels as a useful staging tool in different stages of transitional cell carcinoma of the bladder and renal cell carcinoma.

Authors:  A Hegele; R Hofmann; B Kosche; J Kropf
Journal:  Biomark Insights       Date:  2007-02-07

4.  Fibronectin 1 protein expression in clear cell renal cell carcinoma.

Authors:  S Steffens; A J Schrader; Gesa Vetter; H Eggers; H Blasig; J Becker; M A Kuczyk; J Serth
Journal:  Oncol Lett       Date:  2012-01-12       Impact factor: 2.967

5.  Cyclic RGD-targeting of reversibly stabilized DNA nanoparticles enhances cell uptake and transfection in vitro.

Authors:  Qing-Hui Zhou; Ye-Zi You; Chao Wu; Yi Huang; David Oupický
Journal:  J Drug Target       Date:  2009-06       Impact factor: 5.121

6.  A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting.

Authors:  Eric B Berens; Jon M Holy; Anna T Riegel; Anton Wellstein
Journal:  J Vis Exp       Date:  2015-11-20       Impact factor: 1.355

7.  An inhibitor of a cell adhesion receptor stimulates cell migration.

Authors:  Shagufta H Shabbir; Jessica L Eisenberg; Milan Mrksich
Journal:  Angew Chem Int Ed Engl       Date:  2010-10-11       Impact factor: 15.336

8.  Integrin α5 triggers the metastatic potential in renal cell carcinoma.

Authors:  Dirk Prawitt; Walburgis Brenner; Ines Breuksch; Franz Prosinger; Fabian Baehr; Franz-Peter Engelhardt; Heide-Katharina Bauer; Joachim W Thüroff; Anne-Sophie Heimes; Annette Hasenburg
Journal:  Oncotarget       Date:  2017-11-18

9.  In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.

Authors:  Ines Breuksch; Jonas Welter; Heide-Katharina Bauer; Thorsten Enklaar; Sebastian Frees; Joachim W Thüroff; Annette Hasenburg; Dirk Prawitt; Walburgis Brenner
Journal:  Cell Commun Signal       Date:  2018-06-28       Impact factor: 5.712

10.  Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranes.

Authors:  Jon Jones; Stefan Berkhoff; Eva Weich; Tobias Engl; Steffen Wedel; Borna Relja; Dietger Jonas; Roman A Blaheta
Journal:  J Cell Mol Med       Date:  2007 Jul-Aug       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.